Wird geladen...
Immune checkpoint inhibitor therapy for pediatric cancers: A mini review of endocrine adverse events
In recent years, immune checkpoint inhibitor therapy has attracted a great deal of attention in the field of cancer treatment. In the clinical setting, antibodies targeting programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) have been successfully used to treat ad...
Gespeichert in:
| Veröffentlicht in: | Clin Pediatr Endocrinol |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Japanese Society for Pediatric Endocrinology
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6646237/ https://ncbi.nlm.nih.gov/pubmed/31384097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.28.59 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|